tiprankstipranks
Trending News
More News >
COMPASS Pathways (DE:5Y6)
FRANKFURT:5Y6
Germany Market
Advertisement

COMPASS Pathways (5Y6) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

5Y6 Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
COMPASS
Pathways
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

5Y6 Stock 12 Month Forecast

Average Price Target

€15.86
▲(166.58% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is €15.86 with a high forecast of €34.43 and a low forecast of €8.61. The average price target represents a 166.58% change from the last price of €5.95.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","18":"€18","35":"€35","9.5":"€9.5","26.5":"€26.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34.4259856,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€34.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.8617728652,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.6064964,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€8.61</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,9.5,18,26.5,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.78,7.060460430769231,9.34092086153846,11.621381292307692,13.901841723076924,16.182302153846155,18.462762584615383,20.743223015384615,23.023683446153846,25.304143876923078,27.58460430769231,29.865064738461538,32.145525169230766,{"y":34.4259856,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.78,5.632444066553846,6.484888133107693,7.337332199661539,8.189776266215386,9.042220332769233,9.894664399323078,10.747108465876924,11.59955253243077,12.451996598984618,13.304440665538465,14.156884732092308,15.009328798646155,{"y":15.8617728652,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.78,5.074345876923077,5.368691753846154,5.663037630769231,5.957383507692308,6.251729384615384,6.546075261538461,6.840421138461538,7.1347670153846146,7.429112892307692,7.723458769230769,8.017804646153845,8.312150523076923,{"y":8.6064964,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.45,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.94,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.62,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.12,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.62,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.78,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€34.43Average Price Target€15.86Lowest Price Target€8.61
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
€12.05
Buy
102.51%
Upside
Reiterated
10/13/25
Buy Rating for COMPASS Pathways: Strong Position in Psychedelic Treatment and Clinical Excellence
H.C. Wainwright Analyst forecast on DE:5Y6
H.C. Wainwright
H.C. Wainwright
€38.73€34.43
Buy
478.59%
Upside
Reiterated
09/23/25
H.C. Wainwright Sticks to Their Buy Rating for COMPASS Pathways (CMPS)
Canaccord Genuity Analyst forecast on DE:5Y6
Canaccord Genuity
Canaccord Genuity
€12.91
Buy
116.97%
Upside
Reiterated
08/14/25
Optimistic Buy Rating for COMPASS Pathways Amidst Promising Phase 3 Trials and Regulatory Support
Morgan Stanley Analyst forecast on DE:5Y6
Morgan Stanley
Morgan Stanley
€8.61
Buy
44.65%
Upside
Initiated
08/08/25
COMPASS Pathways (CMPS) Receives a New Rating from Morgan Stanley
Maxim Group
€10.33
Buy
73.58%
Upside
Reiterated
08/04/25
COMPASS Pathways: Leading the Psychedelic Medicine Revolution with Promising Psilocybin Trials and Strong Industry Positioning
TD Cowen Analyst forecast on DE:5Y6
TD Cowen
TD Cowen
€19.79
Buy
232.69%
Upside
Reiterated
07/31/25
Positive Buy Rating for COMPASS Pathways Driven by Strategic Progress and Financial Stability
RBC Capital Analyst forecast on DE:5Y6
RBC Capital
RBC Capital
€12.91
Buy
116.97%
Upside
Reiterated
07/31/25
Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Alnylam Pharma (NASDAQ: ALNY) and COMPASS Pathways (NASDAQ: CMPS)
Evercore ISI
€9.47€5.16
Hold
-13.21%
Downside
Downgraded
07/11/25
COMPASS Pathways (CMPS) was downgraded to a Hold Rating at Evercore ISI
Stifel Nicolaus Analyst forecast on DE:5Y6
Stifel Nicolaus
Stifel Nicolaus
€9.47
Buy
59.11%
Upside
Reiterated
06/30/25
Cantor Fitzgerald Analyst forecast on DE:5Y6
Cantor Fitzgerald
Cantor Fitzgerald
€10.33
Buy
73.58%
Upside
Initiated
05/27/25
Cantor Fitzgerald Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)
TR | OpenAI - 4o Analyst forecast on DE:5Y6
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
04/24/25
AI Generated ArticleAI Generated Article
Lucid Capital Analyst forecast on DE:5Y6
Lucid Capital
Lucid Capital
€25.82€7.75
Buy
30.18%
Upside
Reiterated
01/27/25
Compass Pathways (CMPS) PT Lowered to $9 at Rodman RenshawRodman Renshaw analyst Elemer Piros lowered the price target on Compass Pathways (NASDAQ: CMPS) to $9.00 (from $30.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
€12.05
Buy
102.51%
Upside
Reiterated
10/13/25
Buy Rating for COMPASS Pathways: Strong Position in Psychedelic Treatment and Clinical Excellence
H.C. Wainwright Analyst forecast on DE:5Y6
H.C. Wainwright
H.C. Wainwright
€38.73€34.43
Buy
478.59%
Upside
Reiterated
09/23/25
H.C. Wainwright Sticks to Their Buy Rating for COMPASS Pathways (CMPS)
Canaccord Genuity Analyst forecast on DE:5Y6
Canaccord Genuity
Canaccord Genuity
€12.91
Buy
116.97%
Upside
Reiterated
08/14/25
Optimistic Buy Rating for COMPASS Pathways Amidst Promising Phase 3 Trials and Regulatory Support
Morgan Stanley Analyst forecast on DE:5Y6
Morgan Stanley
Morgan Stanley
€8.61
Buy
44.65%
Upside
Initiated
08/08/25
COMPASS Pathways (CMPS) Receives a New Rating from Morgan Stanley
Maxim Group
€10.33
Buy
73.58%
Upside
Reiterated
08/04/25
COMPASS Pathways: Leading the Psychedelic Medicine Revolution with Promising Psilocybin Trials and Strong Industry Positioning
TD Cowen Analyst forecast on DE:5Y6
TD Cowen
TD Cowen
€19.79
Buy
232.69%
Upside
Reiterated
07/31/25
Positive Buy Rating for COMPASS Pathways Driven by Strategic Progress and Financial Stability
RBC Capital Analyst forecast on DE:5Y6
RBC Capital
RBC Capital
€12.91
Buy
116.97%
Upside
Reiterated
07/31/25
Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Alnylam Pharma (NASDAQ: ALNY) and COMPASS Pathways (NASDAQ: CMPS)
Evercore ISI
€9.47€5.16
Hold
-13.21%
Downside
Downgraded
07/11/25
COMPASS Pathways (CMPS) was downgraded to a Hold Rating at Evercore ISI
Stifel Nicolaus Analyst forecast on DE:5Y6
Stifel Nicolaus
Stifel Nicolaus
€9.47
Buy
59.11%
Upside
Reiterated
06/30/25
Cantor Fitzgerald Analyst forecast on DE:5Y6
Cantor Fitzgerald
Cantor Fitzgerald
€10.33
Buy
73.58%
Upside
Initiated
05/27/25
Cantor Fitzgerald Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)
TR | OpenAI - 4o Analyst forecast on DE:5Y6
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
04/24/25
AI Generated ArticleAI Generated Article
Lucid Capital Analyst forecast on DE:5Y6
Lucid Capital
Lucid Capital
€25.82€7.75
Buy
30.18%
Upside
Reiterated
01/27/25
Compass Pathways (CMPS) PT Lowered to $9 at Rodman RenshawRodman Renshaw analyst Elemer Piros lowered the price target on Compass Pathways (NASDAQ: CMPS) to $9.00 (from $30.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering COMPASS Pathways

1 Month
xxx
Success Rate
11/22 ratings generated profit
50%
Average Return
+6.17%
reiterated a xxx
rating 25 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +6.17% per trade.
3 Months
xxx
Success Rate
7/12 ratings generated profit
58%
Average Return
+6.70%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +6.70% per trade.
1 Year
Ritu BaralTD Cowen
Success Rate
5/12 ratings generated profit
42%
Average Return
+4.68%
reiterated a buy rating 3 months ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.68% per trade.
2 Years
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+10.33%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +10.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

5Y6 Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
18
19
17
11
9
Buy
0
0
0
0
0
Hold
1
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
20
18
12
9
In the current month, 5Y6 has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 5Y6 average Analyst price target in the past 3 months is 15.86.
Each month's total comprises the sum of three months' worth of ratings.

5Y6 Financial Forecast

5Y6 Earnings Forecast

Next quarter’s earnings estimate for 5Y6 is -€0.34 with a range of -€0.43 to -€0.19. The previous quarter’s EPS was -€0.35. 5Y6 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 5Y6 has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 5Y6 is -€0.34 with a range of -€0.43 to -€0.19. The previous quarter’s EPS was -€0.35. 5Y6 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 5Y6 has Preformed in-line its overall industry.
No data currently available

5Y6 Sales Forecast

Next quarter’s sales forecast for 5Y6 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 5Y6 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 5Y6 has Preformed in-line its overall industry.
Next quarter’s sales forecast for 5Y6 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 5Y6 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 5Y6 has Preformed in-line its overall industry.

5Y6 Stock Forecast FAQ

What is DE:5Y6’s average 12-month price target, according to analysts?
Based on analyst ratings, COMPASS Pathways’s 12-month average price target is 15.86.
    What is DE:5Y6’s upside potential, based on the analysts’ average price target?
    COMPASS Pathways has 166.58% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is COMPASS Pathways a Buy, Sell or Hold?
          COMPASS Pathways has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is COMPASS Pathways’s share price target?
            The average share price target for COMPASS Pathways is 15.86. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €34.43 ,and the lowest forecast is €8.61. The average share price target represents 166.58% Increase from the current price of €5.95.
              What do analysts say about COMPASS Pathways?
              COMPASS Pathways’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of COMPASS Pathways?
                To buy shares of DE:5Y6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis